An ISA to Master Protocol ARGX-999-2-MG-2000 for an Exploratory, Phase 2a, Proof-of-Concept Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart IV as Add-On Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07284420

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:29:04.575449+00:00

Published At

2026-04-23T00:00:00+00:00

Record Updated At

2026-04-23

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["AChR-Ab Seropositive Generalized Myasthenia Gravis", "Myasthenia Gravis", "MG", "gMG", "Generalized Myasthenia Gravis", "Generalized Myasthenia Gravis (gMG)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-23"

protocolSection.identificationModule.nctId

"NCT07284420"

protocolSection.identificationModule.officialTitle

"An ISA to Master Protocol ARGX-999-2-MG-2000 for an Exploratory, Phase 2a, Proof-of-Concept Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart IV as Add-On Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• AChR-Ab Seropositive Generalized Myasthenia Gravis (protocolSection.conditionsModule.conditions)
• Myasthenia Gravis (protocolSection.conditionsModule.conditions)
• MG (protocolSection.conditionsModule.conditions)
• gMG (protocolSection.conditionsModule.conditions)
• Generalized Myasthenia Gravis (protocolSection.conditionsModule.conditions)
• Generalized Myasthenia Gravis (gMG) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.